Taken together, corporate disclosure documents (2019), peer-produced scientific publications (2019, 2021–2022, 2023), and official media interviews (2025) establish a continuous line of institutional affiliation between Peng Shuangqing and China’s military medical research system. The absence of a current director title does not indicate disengagement. Instead, Peng’s ongoing authorship under PLA affiliations, combined with his identification in 2025 as an AMMS researcher, demonstrates role transition without institutional separation—from administrative leadership to senior research and advisory functions within the same bio-warfare program framework.
#Democracy #Christ #Peace #Freedom #Liberty #Humanrights #人权 #法治 #宪政 #独立审计 #司法独立 #联邦制 #独立自治
No comments:
Post a Comment